72.11.Z - Research and experimental development on biotechnology
01.43.Z - Raising of horses and other equines
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
58.19.Z - Other publishing activities
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
75.00.Z - Veterinary activities
82.99.Z - Other business support service activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -74,3 | -93 | -89,7 | 3,6 |
Gross profit (loss) | -53,3 | -89,7 | -86,3 | 3,8 |
EBITDA | -74,3 | -93,1 | -90,1 | 3,1 |
Short time liabilities | 17,7 | 27 | 16,9 | -37,7 |
Other operating costs | 0 | 0 | 0,4 | 3402,6 |
Equity capital | 297,5 | 207,9 | 121,6 | -41,5 |
Operating profit (EBIT) | -74,3 | -93,1 | -90,1 | 3,1 |
Assets | 315,2 | 234,9 | 138,5 | -41,1 |
Net profit (loss) | -53,3 | -89,7 | -86,3 | 3,8 |
Cash | 11,7 | 0,5 | 1,5 | 226,9 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 17,7 | 27 | 16,9 | -37,7 |
Working assets | 314,9 | 234,6 | 138,1 | -41,1 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -17,9 | -43,1 | -70,9 | -27,8 |
Equity capital to total assets | 94,4 | 88,5 | 87,8 | -0,7 |
Gross profit margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 17.81700325012207 | 8.674071311950684 | 8.194683074951172 | -0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane